Lopreeza
These highlights do not include all the information needed to use LOPREEZA safely and effectively. See full prescribing information for LOPREEZA. LOPREEZA (estradiol/norethindrone acetate) tablets, for oral use Initial U.S. Approval: 1998
bf0e39cb-95e7-4831-92d2-0b3f071aeaae
HUMAN PRESCRIPTION DRUG LABEL
Nov 30, 2017
Amneal Pharmaceuticals NY LLC
DUNS: 123797875
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
estradiol/norethindrone acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
estradiol/norethindrone acetate
Product Details
FDA regulatory identification and product classification information